Spedding Research Solutions

Executive Summary

Spedding Research Solutions (SRS) is a French contract research organization (CRO) and consultancy based in Lyon, founded in 2015. The company specializes in formulation development, analytical services, and strategic management of research consortia for pharmaceutical and biotech clients. SRS also conducts internal drug discovery research focused on complex diseases, leveraging lateral thinking and experimental validation to uncover novel therapeutic approaches. With expertise spanning early-stage development to consortium oversight, SRS positions itself as a versatile partner bridging academic insights and industrial R&D needs. Despite its niche focus, the company operates in a competitive CRO landscape, but its dual revenue model—fee-for-service plus proprietary discovery—provides diversification and potential upside from internal programs.

Upcoming Catalysts (preview)

• Q3 2026Announcement of a major pharma partnership or consortium award60% success
• Q4 2026Milestone achievement in internal drug discovery program (e.g., lead optimization or preclinical candidate nomination)50% success
• Q2 2026Grant or non-dilutive funding for a collaborative research project70% success